Publication
The New Authority in Biotech Intelligence & Life Sciences Innovation
Helixgate Biotech Review is a high-tech digital global intelligence publication & platform delivering precise insight into the technologies, companies, and capital shaping the future of biotechnology.
A High-Tech Digital Global Intelligence Publication & Platform
Helixgate Biotech Review operates as a centralized intelligence layer across the global biotechnology ecosystem. We combine the structured distribution of a publication with the analytical depth and connectivity of a platform.
Beyond Traditional Publications
Curated Intelligence
We deliver high-signal intelligence, moving beyond surface-level news reporting.
Strategic Visibility
Providing structured access to high-value opportunities in life sciences.
Areas of Coverage
AI / ML Systems
Technologies transforming drug discovery and predictive modeling.
Therapeutic Innovation
Small molecules, biologics, and novel treatment pathways.
Synthetic Biology
Advanced biomaterials and scalable compound production.
Capital & Industry
Strategic partnerships, funding activity, and infrastructure expansion.
Who We Serve
Our platform is designed for biotech executives, venture capital firms, scientific leaders, and infrastructure developers operating at the center of industry transformation.
Global Reach. Strategic Focus.
Operating across major biotechnology and life sciences corridors globally.
Positioned at the Center of Transformation
Bridge the gap between discovery and deployment.
Leadership
Founder
Mason Strathmore
Founder & Publisher
Helixgate Biotech Review
Mason Strathmore founded Helixgate Biotech Review to create a platform exploring the intersection of biotechnology innovation, artificial intelligence, and emerging life‑science technologies.